Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
應用
Dihydronarwedine is a metabolite of Galanthamine (G188500), a selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer’s disease and disorders resulting from reduced neuronal metabolism.
參考文獻
Koizumi, J., et al.: Chem. Pharma. Bull., 12, 696 (1964); Friess, S.L., et al.: Toxicol. Appl. Pharmacol., 3, 347 (1961); Bickel, U., et al.: Clin. Pharmacol. Ther., 50, 420 (1991); Harvey, A.L., et al.: Pharmacol. Ther., 68, 113 (1995)
滬ICP備17019645號
400-821-0725
